Understanding the Importance of Screening and Utility of Clinical Assessment Tools for Early Stages of Alzheimer's Disease

Released On
January 24, 2022

Expires On
January 24, 2023

Media Type
Internet

Completion Time
30 minutes

Specialty
Primary care providers (physicians, nurse practitioners, and physician assistants) and neurologists, particularly community neurologists.

Topic(s)
Diagnosis, Medicare Annual Wellness Visit, Cognitive Assessment Tools, Alzheimer’s Disease, Dementia, Cognitive, Functional, Behavioral, Mild Cognitive Impairment, Biomarkers

Scroll to the Bottom of this Information to Begin this Course

This educational activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Spire Learning.

This activity is supported by an independent educational grant from Biogen MA, Inc.

Credit Available

  • Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

The target audience for this educational initiative is primary care providers (physicians, nurse practitioners, and physician assistants) and neurologists, particularly community neurologists.

Program Overview

Alzheimer’s disease (AD) is the most common cause of dementia, with growing prevalence as the United States population ages. In older adults, the differences between normal age-related cognitive changes and the cognitive changes of Alzheimer’s dementia can be subtle; as such, the diagnosis of early AD requires clinicians to accurately assess and track patient cognition, function, and behavior over time through the effective use of validated assessment tools. However, despite modern clinical advancements evolving our understanding of AD, many patients with AD are either misdiagnosed or diagnosed late in the course of disease, and as a result may not be recognized for inclusion in ongoing clinical trials. Join our expert faculty as they provide a foundational review of the differences between normal aging and cognitive, functional, as well as behavioral domain changes that occur during the early stages of AD. Understand the importance of recognizing early signs of mild cognitive impairment (MCI) and the utility of using validated clinical assessment tools to achieve early and accurate diagnosis.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • DIFFERENTIATE between normal aging and cognitive, functional, and behavioral domain changes that occur during the early stages of AD
  • DESCRIBE the strengths and limitations of assessment tools used in clinical practice and clinical research settings for the screening and diagnosis of early AD
  • EMPLOY best clinical practices for the screening and diagnosis of early AD, including the use of validated clinical assessment toolsE

 

Faculty

R. Scott Turner, MD, PhD

Director, Memory Disorders Program
Vice Chair for Clinical Research
Professor, Department of Neurology
Georgetown University Medical Center
Washington, DC

Eric G. Rodriguez, MD, MPH

Associate Professor of Medicine
University of Pittsburgh School of Medicine
Medical Director of Collaborative Care Management
University of Pittsburgh Medical Center
Pittsburgh, PA

Physician Accreditation and Credit Statement

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Spire Learning, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team..

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The planners and faculty must disclose to the participants any significant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients or with the commercial supporter of this accredited continuing education activity. Identified conflicts of interest are mitigated by AKH prior to the planners/faculty assuming their role in this accredited continuing education activity.

R. Scott Turner, MD, PhD
  • Researcher: Alector; Biogen; Eisai Inc; Eli Lilly and Co; Roche

Eric G. Rodriguez, MD, MPH has no financial relationship with any commercial interests to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated.

Educational Planning Committee

AKH Inc., Advancing Knowledge in Healthcare
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Spire Learning
Mairead Early, Andrew Kim, and Allison Goldberg, MPA: No relevant financial relationships with ineligible companies to disclose.

AKH Reviewer
Bernadette Makar, MSN, APRN-BC, NP-C: No relevant financial relationships with any commercial interests.

Instructions for Participation and Credit

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at JGoldman@akhcme.com.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Statement

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Privacy Policy

AKH Inc., Advancing Knowledge in Healthcare https://www.akhcme.com/privacy-policy/"

Spire Learning Privacy Policy:
Spire Learning, LLC, is committed to protecting the privacy of personal information from our participants and educational collaborators. Spire maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of personal information.

Collection and Use of Your Personal Information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected and retained, and used by Spire Learning, LLC, to continuously improve the learning experience.

Spire Learning, LLC, will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Spire will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.

Copyright Information

Copyright © 2022 by Spire Learning, LLC and AKH Inc., Advancing Knowledge in Healthcare. All rights reserved including translation into other languages. No part of this publication or activity may be reproduced or transmitted in any form, by any means, without prior written permission of Spire Learning, LLC.

Contact Information

If you have questions about this activity, please contact AKH Inc. at JGoldman@akhcme.com.